https://www.ox.ac.uk/news/2020-11-11-oxford-univer
Post# of 22453
Forty different lateral flow devices were put forward, of which nine met the criteria to continue to full evaluation. Six made it to the third phase, and the Innova SARS-CoV-2 Antigen Rapid Qualitative Test, the test being used in the Liverpool pilot, is nearing completion of the four-stage process.
Sir John Bell, Regius Professor of Medicine at Oxford University, said: 'The data in this validation report demonstrates that these inexpensive, easy to use tests can play a major role in our fight against COVID 19.
'They identify those who are likely to spread the disease and when used systematically in mass testing could reduce transmissions by 90%.